Resources
Publications
News
Inside Our First MoBi® Summer School: A Hands-On Advanced PBPK & QSP Modeling Training
Earlier this month, for the first time ever, our team ran a four-day intensive training on advanced Physiologically Based Pharmacokinetic (PBPK) and Quantitative Systems Pharmacology (QSP) modeling and simulation. [...]
Where PBPK Meets the Chip: Notes from the MPS World Summit Through a PBPK Modeler’s Lens
Last week, the MPS World Summit took place at the Walter E. Washington Convention Center in Washington, DC, from May 26–29, 2026. Our MPSlabs team had a poster accepted for presentation. [...]
ESQlabs at the International workshop towards harmonisation of QIVIVE in risk assessment
Last week, our colleagues Dr. Stella Fragki and Dr. Susana Proença attended the international workshop on QIVIVE (Quantitative In Vitro to In Vivo Extrapolation), representing our ESQlabs team. The [...]
PBPK for Drug-Drug Interactions: Why It Matters
If you are in drug development, there is one question regulators will almost certainly ask: How does your compound interact with other drugs? Drug-Drug Interaction (DDI) assessment is the dominant application [...]
ESQlabs Brings Next-Generation Risk Assessment to the United States
ESQlabs, a European leader in physiologically based kinetic (PBPK) modeling, and Quantitative Systems Toxicology, has officially established a presence in the United States, bringing its science-forward approach to drug and chemical safety assessment to North American clients [...]
Our latest Face to Face was once again, a meeting to remeber
This time, we gathered in Athens: a city rich in history, yet vibrant, welcoming, and truly inspiring, perfectly reflecting the spirit of our company. Most of our team arrived [...]
